As of 2026-03-27, the Relative Valuation of Treace Medical Concepts Inc (TMCI) is (30.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.28 USD, the upside of Treace Medical Concepts Inc based on Relative Valuation is -2471.1%.
The range of the Relative Valuation is (29.87) - (29.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.7x - 37.8x | 36.3x |
| Forward P/E multiples | 25.8x - 32.4x | 30.1x |
| Fair Price | (29.87) - (29.58) | (30.35) |
| Upside | -2433.7% - -2410.8% | -2471.1% |
| Date | P/E |
| 2026-03-26 | -1.40 |
| 2026-03-25 | -1.38 |
| 2026-03-24 | -1.37 |
| 2026-03-23 | -1.38 |
| 2026-03-20 | -1.36 |
| 2026-03-19 | -1.43 |
| 2026-03-18 | -1.48 |
| 2026-03-17 | -1.60 |
| 2026-03-16 | -1.55 |
| 2026-03-13 | -1.60 |
| 2026-03-12 | -1.48 |
| 2026-03-11 | -1.52 |
| 2026-03-10 | -1.62 |
| 2026-03-09 | -1.81 |
| 2026-03-06 | -1.57 |
| 2026-03-05 | -1.52 |
| 2026-03-04 | -1.61 |
| 2026-03-03 | -1.72 |
| 2026-03-02 | -1.82 |
| 2026-02-27 | -2.04 |
| 2026-02-26 | -2.30 |
| 2026-02-25 | -2.23 |
| 2026-02-24 | -2.16 |
| 2026-02-23 | -2.20 |
| 2026-02-20 | -2.07 |
| 2026-02-19 | -2.10 |
| 2026-02-18 | -2.03 |
| 2026-02-17 | -2.00 |
| 2026-02-13 | -2.04 |
| 2026-02-12 | -2.08 |
| 2026-02-11 | -2.21 |
| 2026-02-10 | -2.29 |
| 2026-02-09 | -2.42 |
| 2026-02-06 | -2.47 |
| 2026-02-05 | -2.23 |
| 2026-02-04 | -2.32 |
| 2026-02-03 | -2.29 |
| 2026-02-02 | -2.47 |
| 2026-01-30 | -2.54 |
| 2026-01-29 | -2.52 |
| 2026-01-28 | -2.63 |
| 2026-01-27 | -2.78 |
| 2026-01-26 | -2.74 |
| 2026-01-23 | -2.82 |
| 2026-01-22 | -2.94 |
| 2026-01-21 | -2.86 |
| 2026-01-20 | -2.85 |
| 2026-01-16 | -2.89 |
| 2026-01-15 | -2.90 |
| 2026-01-14 | -2.96 |